ADAMI, FAUSTO
 Distribuzione geografica
Continente #
NA - Nord America 6.239
EU - Europa 1.036
AS - Asia 528
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 7.813
Nazione #
US - Stati Uniti d'America 6.236
DE - Germania 420
CN - Cina 404
FI - Finlandia 160
RU - Federazione Russa 104
IT - Italia 92
SE - Svezia 83
UA - Ucraina 75
GB - Regno Unito 73
VN - Vietnam 50
SG - Singapore 45
IN - India 18
IE - Irlanda 17
JP - Giappone 7
BR - Brasile 5
EU - Europa 4
FR - Francia 4
GR - Grecia 3
TR - Turchia 3
CA - Canada 2
CH - Svizzera 2
NL - Olanda 2
AU - Australia 1
ES - Italia 1
MX - Messico 1
SA - Arabia Saudita 1
Totale 7.813
Città #
Fairfield 1.000
Woodbridge 770
Ann Arbor 583
Chandler 513
Ashburn 416
Houston 408
Cambridge 401
Jacksonville 391
Wilmington 375
Seattle 352
Princeton 170
San Diego 102
Beijing 94
Nanjing 81
Medford 76
Des Moines 70
Dong Ket 50
Helsinki 50
Guangzhou 43
Boardman 41
Shenyang 32
Singapore 27
Padova 25
Norwalk 21
Nanchang 20
Hebei 19
Dublin 17
Jiaxing 17
Roxbury 17
Jinan 15
Changsha 14
New York 14
Shanghai 11
Tianjin 10
Pune 8
Redwood City 8
London 6
Shibuya 6
Indiana 5
Los Angeles 5
Bolzano 4
Hangzhou 4
Hefei 4
Kharkiv 4
Washington 4
Borås 3
Haikou 3
Kilburn 3
Miami 3
Ningbo 3
Ogden 3
Pisa 3
Tappahannock 3
Yenibosna 3
Zhengzhou 3
Düsseldorf 2
El Paso 2
Falkenstein 2
Fuzhou 2
Goiânia 2
Guarulhos 2
Hanover 2
Istrana 2
Kunming 2
Milan 2
Naples 2
Quzhou 2
Redmond 2
Rome 2
Salerno 2
Taiyuan 2
Taizhou 2
Toronto 2
Turin 2
Vicenza 2
Acton 1
Ahmedabad 1
Almere Stad 1
Amsterdam 1
Baotou 1
Basel 1
Belpasso 1
Bolton 1
Boston 1
Caltagirone 1
Caorle 1
Catania 1
Cermenate 1
Chiswick 1
Chongqing 1
Duncan 1
Frankfurt Am Main 1
Frankfurt am Main 1
Gloucester 1
Gurgaon 1
Harbin 1
Islington 1
Isola Vicentina 1
Lanzhou 1
Lappeenranta 1
Totale 6.398
Nome #
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma 142
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 140
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. 133
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia 131
Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B. 130
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity 127
Acute decompensated heart failure in young woman with lymphoproliferative disorder 127
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma 122
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 118
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells 117
A UNIQUE CASE OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS FOLLOWING DEXAMETHASONE/BORTEZOMIB/THALIDOMIDE TREATMENT FOR MYELOMA 117
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 113
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia 108
Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy. 106
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients 106
Cobalamin deficiency: clinical picture and radiological findings. 102
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity 102
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death 102
Immunomodulatory drugs in plasma cell diseases: everything has its price 99
How nature preserves fetuses 98
Multifocal neurological involvement as the only manifestation of IgG4-related disease. 95
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study. 95
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis 95
Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 95
Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy. 94
Sporadic transthyretin amyloidosis with a novel TTR gene mutation, misdiagnosed as primary amyloidosis. 94
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders 93
Free light chains and heavy/light chains in monitoring POEMS patients. 88
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response 87
B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation 83
Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. 82
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process 82
Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent 81
Serum free light chain reference values: A critical approach. 81
Expression and regulation of tumor necrosis factor, interleukin-2,and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia 78
Relapsing Leukemia Infiltrating the Heart 78
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia. 77
Multiple myeloma cell survival relies on high activity of protein kinase CK2 76
Application of confocal laser scanning microscopy for the diagnosis of amyloidosis 76
Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome. 75
Chemokine receptors involvement in B-cell lymphoproliferative disorders. 74
Immune mechanisms in interstitial lung diseases 74
Expression and functional role of chemokine receptors in multiple myeloma 74
SERUM LEVELS OF SOLUBLE CD8 ARE INCREASED IN PATIENTS WITH B CHRONIC LYMPHOCYTIC LEUKEMIA. 71
Expression and functional role of chemokine receptors in multiple myeloma 70
A CD5+ leukemic lymphoma with monocytoid features: an unusual B-cell lymphoma mimicking hairy-cell leukemia. 69
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern 69
Adhesion molecules on human myeloma (MM) cells might clarify different clinical outcome 68
Expression and functional role of CXCR3 on malignant B cells from patients with B-cell chronic disorders 68
CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas. 68
Images in cardiovascular medicine. Right atrial mass in a patient with T-cell chronic lymphocytic leukemia: an unusual mechanism of thrombus formation. 68
High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. 68
Coexistence of primary AL amyloidosis and POEMS syndrome: efficacy of melphalan-dexamethasone and role of biochemical markers in monitoring the diseases course. 67
Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography 67
PROPOSTA DI MONITORAGGIO IMMUNOLOGICO IN PAZIENTI CON CARCINOMA SQUAMOSO DEL LARINGE. 66
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. 66
Visceral leishmaniasis complicating chronic hepatitis B treated with interferon. 65
The chemokine receptor CXCR3 is expressed on malgnat B cells and mediates chemotaxis. 64
Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B 64
Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. 64
Polyneuropathy, Organomegaly, Endocrinopathy, M protein, Skin changes: not always a POEMS syndrome. 63
Prognostic factors in malignant transformation of monoclonal gammopathy of undetermined significance 63
THE PEDIATRIC RHABDOMYOSARCOMA TRANSLOCATION T(2;13)(Q35;Q14) IN B-PROLYMPHOCYTIC LEUKEMIA. 62
Expression and functional properties of costimulatory molecules in patients with B cell chronic lymphoproliferative disorders. 61
SOLUBLE FAS, TNF-RI AND TNF-RII IN HEPATITIS C VIRUS INFECTION WITH AND WITHOUT EXTRAHEPATIC MANIFESTATIONS 60
Cyclosporin A and dexamethasone induce apoptosis in malignant cells of patients with B-chronic lymphocytic leukemia 60
Prognostic value of heavy-chain gene mutation status and ZAP-70 expression in 113 CLL patients from a single institution 59
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial 59
CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. 58
Coexistence of primary AL amyloidosis and POEMS syndrome. 57
Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome. 57
Bortezomib-Dexamethasone As Inducion Therapy for Light Chain Deposition Disease (LCDD): A Single Center Experience 56
Monoclonal Gammopathy of Undetermined Significance (MGUS) after Liver Transplantation: A Risk Factor for Long-Term Medical Complications Other Than Malignancy 54
SOLUBLE FAS, TNF RI AND TNF RII IN HEPATITIS C VIRUS INFECTION WITH AND WITHOUT EXTRAHEPATIC MANIFESTATIONS 53
Chemokine receptors and adhesion molecules involvement in multiple myeloma 53
CK2 serine-threonine kinase controls multiple myeloma cells survival and proliferation and its selective block leads to growth arrest, apoptosis and altered NFKB signaling 52
Monoclonal Gammopathy of Undetermined Significance (MGUS) after Liver Transplantation: A Risk Factor for Long-Term Medical Complications Other Than Malignancy 52
B7 molecules are expressed on malignat cells in patients with B-cell chronic disorders and trigger T-lymphocyte proliferation. 50
New pathogenetic insights into the sarcoid granuloma 50
Chemokine receptors involvement in B-cell lymphoproliferative disorders. 50
INTERLEUKINA-2 E CELLULE LAK: UN NUOVO APPROCCIO PER LA TERAPIA DEI TUMORI. 49
Poems and amyloidosis: Coexistence of two plasma cell disorders with one neuropathy. 48
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis 48
null 48
Chemokine receptors and adhesion molecules involvement in multiple myeloma. 48
Homestatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. 46
Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors 46
Expression and functional role of chemokine receptors in multiple myeloma 45
Human myeloma cells express the CD38 ligand CD31. 45
Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells 44
Expression and functional role of the p75 interleukin-2 receptor chain on leukemic hairy cells 44
Prognostic value of bone marrow biopsy in malignant transformation of monoclonal gammopathies of undetermine significance 40
Sarcoidosis 40
High levels of soluble TNF superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. 40
PHA-induced, antibody-mediated and spontaneous cellular cytotoxicity toward chicken red blood cells in solid carcinomas and glioblastomas. 40
[Plummer-Vinson syndrome: etiopathogenetic considerations and description of a case]. 39
Aspetti fenotipici e biologici nella hairy cell leukemia. 38
Immunohistochemical detection of microenvironmental abnormalities in lung biopsies from patients with sarcoidosis. 37
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. 36
SINDROME DI PLUMMER-VINSON: CONSIDERAZIONI EZIOPATOGENETICHE E DESCRIZIONE DI UN CASO. 35
Totale 7.394
Categoria #
all - tutte 25.437
article - articoli 23.019
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 196
Totale 48.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019198 0 0 0 0 0 0 0 0 0 0 0 198
2019/20201.577 238 48 23 130 157 120 145 183 146 214 86 87
2020/20211.318 146 181 59 80 82 96 54 99 160 82 175 104
2021/20221.362 30 192 192 92 31 72 56 163 63 17 146 308
2022/20231.045 227 98 19 133 172 159 1 65 120 10 29 12
2023/2024424 23 66 45 38 36 57 24 26 12 43 45 9
Totale 7.885